Aptamer Technology in the Targeted Delivery of Doxorubicin- Crimson Publishers
Aptamer Technology in the Targeted Delivery of Doxorubicin by Duaa Dakhlallah in Novel Approaches in Cancer Study
This review aims at giving an insight at some of the recent approaches in
using the aptamer technology in formulating the chemotherapeutic agent,
doxorubicin, so as to achieve its targeted delivery and reduce its
non-specific cytotoxicity.
